Releases


All 2018 Releases
Apr 17, 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program PDF 16.6 KB Add to Briefcase
Apr 13, 2018 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018 PDF 19.4 KB Add to Briefcase
Apr 3, 2018 Veloxis Appoints Morten Marott as Chief Financial Officer  
Mar 31, 2018 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2018 PDF 209.2 KB Add to Briefcase
Mar 28, 2018 Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of ENVARSUS XR® PDF 300.4 KB Add to Briefcase
Mar 22, 2018 Notice to Convene Annual General Meeting 2018 PDF 239.0 KB Add to Briefcase
Mar 16, 2018 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 174.8 KB Add to Briefcase
Mar 7, 2018 Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR® PDF 14.0 KB Add to Briefcase
Feb 27, 2018 Veloxis Pharmaceuticals Releases Annual Report for 2017 PDF 199.7 KB Add to Briefcase
Feb 14, 2018 Veloxis Secures USD 60M in Debt Financing PDF 207.9 KB Add to Briefcase
Showing 1-10 of 10 Page: 1  
=add release to Briefcase